Clinical Care Considerations: Clinical Considerations for Care of Children and Adults with Confirmed COVID-19: Key Points

Details

• Alternative Title:
  Key points
• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated May 27, 2022
  
  • The clinical presentation of COVID-19 varies from asymptomatic infection to critical illness; symptoms can vary over time.
  
  • When testing for current SARS-CoV-2 infection, CDC recommends that clinicians use molecular or antigen tests (viral tests) that detect SARS-CoV-2 or its components, not a serologic test that detects antibodies. A chest radiograph or computerized tomography (CT) images alone are not recommended to diagnose COVID-19.
  
  • Clinicians caring for special populations including children, pregnant and recently pregnant people, people who are moderately or severely immunocompromised, people with confirmed or suspected multisystem inflammatory syndrome, and people with post-COVID conditions may have additional clinical considerations.
  
  • When treating patients with COVID-19, the National Institutes of Health (NIH) recommends that clinicians consider treating patients according to risk of progression to severe COVID-19 or the severity of COVID-19. Patients who are reinfected with SARS-CoV-2 likely will experience less severe illness than during the initial infection, but some patients will experience more severe illness.
  
  
• Subjects:
  Child Child Health Services COVID-19 SARS-CoV-2
• Series:
  Clinical Care Considerations
• Document Type:
  Text
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:5a05c2e6f778516a8e1366bcc0f9940052c5e76b38e642da2acb849a401be85528b51f44b780b65b89bf5310c3e4f36c51fdb77acc4209da9089ca1e940a408f
• Download URL:
  https://stacks.cdc.gov/view/cdc/117891/cdc_117891_DS1.pdf
• File Type:
  [PDF - 471.62 KB ]